HORIBA acquires MedTest Dx and Pointe Scientific to expand laboratory Chemistry offerings

HORIBA, Ltd. (Headquarters in Kyoto, Japan, referred to as HORIBA) and HORIBA Instruments (Headquarters in Irvine, California, USA) announced that it has acquired MedTest Holdings, Inc. (Headquarters in Canton, MI, USA, composed of MedTest Dx, Inc.,

HORIBA, Ltd. (Headquarters in Kyoto, Japan, referred to as HORIBA) and HORIBA Instruments (Headquarters in Irvine, California, USA) announced that it has acquired MedTest Holdings, Inc. (Headquarters in Canton, MI, USA, composed of MedTest Dx, Inc., Pointe Scientific, Inc., Clinitox Diagnostix, Inc., and Medical Laboratory Solutions, Inc.).

The acquisition will combine the complementary innovative technology offerings of the HORIBA Medical segment (referred to as HORIBA Medical) with MedTest Dx technology, Clinitox, and Pointe Scientific’s R&D and manufacturing capabilities, with particular expertise in FDA 510K and CLIA clearances, to address the multidisciplinary requirements of IVD testing customers.

More information

Details

Rue du Caducée, Grabels, France

HORIBA Medical

Associated Trend items

HORIBA Medical launches the Cube S sorter in collaboration with NGNY Devices to enhance laboratory workflows

HORIBA Medical has introduced a new Pre and Post analytical compact sorter, designed and developed by NGNY Devices, to help hematology laboratories gain productivity and efficiency by improving workflows.

The Cube S is a compact robotic workstation that optimizes pre and post analytical sorting, storing and tracking of sample tubes in a laboratory. Cube S can now be integrated with all HORIBA Medical’s hematology platforms, enabling distribution of samples to different destinations. This benchtop instrument automates a number of steps that would otherwise be undertaken m...

More information

HORIBA Medical launches next generation HELO fully automated modular hematology solution

HORIBA Evolutive Laboratory Organisation (HELO) 2.0 embeds advanced hematology technologies to offer flexible, high throughput, high quality analytical performance

HORIBA Medical has launched the new HELO 2.0 high throughput automated hematology platform which is CE-IVDR approved. Following the success of HORIBA Medical’s previous HELO, this new generation high-end hematology range has been designed in consultation with customers to further improve and cover all needs of high throughput fully automated hematology. HELO 2.0 offers a...

More information

Workshop: Assessing Recovery From Thrombocytopenia With CBC Parameters

HORIBA Hematology Online Workshop

Thrombocytopenia, also known as low platelet count, can be caused by either reactive or bone marrow pathologies. Timely assessment of platelet counts helps doctors determine the appropriate medical management. In this workshop, we will focus on the biological changes of platelets in thrombocytopenia and present how a simple complete blood count (CBC) with a surrogate thr...

More information

Compare

Remove all

Compare up to 10 products